Bicycle Therapeutics (BCYC) Non-Current Assets (2018 - 2026)

Bicycle Therapeutics posted quarterly Non-Current Assets of $20.3 million for Q1 2026, up 31.21% year-on-year from $15.4 million in Q1 2025, and down 7.48% on a QoQ basis from $21.9 million in Q4 2025.

Bicycle Therapeutics (BCYC) has 9 years of Non-Current Assets data on file, last reported at $20.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets rose 31.21% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at $20.3 million (up 31.21% YoY), and the FY2025 full-year result was $21.9 million, up 27.45% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $20.3 million, down from $21.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $37.0 million in Q1 2023 and bottomed at $11.4 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $24.8 million (2024), against an average of $24.5 million.
  • The widest annual swing landed in 2022, when Non-Current Assets soared 442.27%; it then slumped 44.58% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $32.8 million in 2022, then decreased by 15.52% to $27.7 million in 2023, then sank by 37.91% to $17.2 million in 2024, then rose by 27.45% to $21.9 million in 2025, then fell by 7.48% to $20.3 million in 2026.
  • The last three Non-Current Assets figures came in at $20.3 million (Q1 2026), $21.9 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 4.56 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 62,953.78
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 5.83 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 910.24 Mn
10 Bicycle Therapeutics 326.82 Mn 326.82 Mn - 20.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.27 Mn
Dec 31, 2025 21.91 Mn
Sep 30, 2025 11.42 Mn
Jun 30, 2025 14.11 Mn
Mar 31, 2025 15.45 Mn
Dec 31, 2024 17.19 Mn
Sep 30, 2024 20.61 Mn
Jun 30, 2024 22.52 Mn
Mar 31, 2024 24.81 Mn
Dec 31, 2023 27.68 Mn
Sep 30, 2023 30.20 Mn
Jun 30, 2023 33.59 Mn
Mar 31, 2023 36.98 Mn
Dec 31, 2022 32.77 Mn
Sep 30, 2022 29.70 Mn
Jun 30, 2022 31.89 Mn
Mar 31, 2022 25.60 Mn
Dec 31, 2021 17.79 Mn
Sep 30, 2021 5.68 Mn
Jun 30, 2021 5.88 Mn
Mar 31, 2021 6.27 Mn
Dec 31, 2020 3.61 Mn
Sep 30, 2020 3.50 Mn
Jun 30, 2020 3.80 Mn
Mar 31, 2020 4.02 Mn
Dec 31, 2019 4.35 Mn
Sep 30, 2019 4.33 Mn
Jun 30, 2019 4.39 Mn
Dec 31, 2018 1.82 Mn